nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—MAPK15—brainstem—pharynx cancer	0.0161	0.0302	CbGeAlD
Sorafenib—CDKL2—head—pharynx cancer	0.00987	0.0185	CbGeAlD
Sorafenib—MAPK15—head—pharynx cancer	0.00889	0.0167	CbGeAlD
Sorafenib—EPHX2—parotid gland—pharynx cancer	0.00725	0.0136	CbGeAlD
Sorafenib—RET—neck—pharynx cancer	0.00708	0.0133	CbGeAlD
Sorafenib—TIE1—epithelium—pharynx cancer	0.00661	0.0124	CbGeAlD
Sorafenib—CDK7—lymphoid tissue—pharynx cancer	0.00644	0.0121	CbGeAlD
Sorafenib—FLT1—neck—pharynx cancer	0.00624	0.0117	CbGeAlD
Sorafenib—RAF1—neck—pharynx cancer	0.0062	0.0116	CbGeAlD
Sorafenib—MAP3K7—parotid gland—pharynx cancer	0.0061	0.0115	CbGeAlD
Sorafenib—MKNK2—parotid gland—pharynx cancer	0.00592	0.0111	CbGeAlD
Sorafenib—MAP3K7—saliva-secreting gland—pharynx cancer	0.00585	0.011	CbGeAlD
Sorafenib—MKNK2—saliva-secreting gland—pharynx cancer	0.00567	0.0106	CbGeAlD
Sorafenib—ZAK—lymphoid tissue—pharynx cancer	0.00556	0.0104	CbGeAlD
Sorafenib—KIT—mouth—pharynx cancer	0.00547	0.0103	CbGeAlD
Sorafenib—FLT4—epithelium—pharynx cancer	0.00546	0.0102	CbGeAlD
Sorafenib—RALBP1—parotid gland—pharynx cancer	0.00534	0.01	CbGeAlD
Sorafenib—KDR—neck—pharynx cancer	0.00527	0.0099	CbGeAlD
Sorafenib—MAPK11—head—pharynx cancer	0.00527	0.00989	CbGeAlD
Sorafenib—CDK7—head—pharynx cancer	0.00519	0.00973	CbGeAlD
Sorafenib—RALBP1—saliva-secreting gland—pharynx cancer	0.00512	0.0096	CbGeAlD
Sorafenib—AURKC—head—pharynx cancer	0.00511	0.00958	CbGeAlD
Sorafenib—FLT1—parotid gland—pharynx cancer	0.00508	0.00954	CbGeAlD
Sorafenib—RAF1—parotid gland—pharynx cancer	0.00505	0.00948	CbGeAlD
Sorafenib—EPHB6—parotid gland—pharynx cancer	0.00502	0.00943	CbGeAlD
Sorafenib—MKNK2—epithelium—pharynx cancer	0.00494	0.00927	CbGeAlD
Sorafenib—FLT1—saliva-secreting gland—pharynx cancer	0.00487	0.00913	CbGeAlD
Sorafenib—RAF1—saliva-secreting gland—pharynx cancer	0.00484	0.00908	CbGeAlD
Sorafenib—RET—epithelium—pharynx cancer	0.00482	0.00905	CbGeAlD
Sorafenib—EPHB6—saliva-secreting gland—pharynx cancer	0.00481	0.00903	CbGeAlD
Sorafenib—RAF1—brainstem—pharynx cancer	0.00474	0.00889	CbGeAlD
Sorafenib—EPHA6—head—pharynx cancer	0.00473	0.00887	CbGeAlD
Sorafenib—KIT—neck—pharynx cancer	0.00467	0.00877	CbGeAlD
Sorafenib—FLT3—lymphoid tissue—pharynx cancer	0.00463	0.00869	CbGeAlD
Sorafenib—PDGFRB—neck—pharynx cancer	0.00456	0.00857	CbGeAlD
Sorafenib—MAP3K7—trachea—pharynx cancer	0.00451	0.00846	CbGeAlD
Sorafenib—ZAK—head—pharynx cancer	0.00448	0.00841	CbGeAlD
Sorafenib—MKNK2—trachea—pharynx cancer	0.00437	0.0082	CbGeAlD
Sorafenib—MAP3K19—head—pharynx cancer	0.0043	0.00807	CbGeAlD
Sorafenib—MAP2K5—parotid gland—pharynx cancer	0.0043	0.00806	CbGeAlD
Sorafenib—KDR—parotid gland—pharynx cancer	0.0043	0.00806	CbGeAlD
Sorafenib—FLT1—epithelium—pharynx cancer	0.00424	0.00797	CbGeAlD
Sorafenib—RAF1—epithelium—pharynx cancer	0.00422	0.00792	CbGeAlD
Sorafenib—FLT4—lymphoid tissue—pharynx cancer	0.0042	0.00789	CbGeAlD
Sorafenib—KDR—saliva-secreting gland—pharynx cancer	0.00411	0.00772	CbGeAlD
Sorafenib—MAP2K5—saliva-secreting gland—pharynx cancer	0.00411	0.00772	CbGeAlD
Sorafenib—TIE1—head—pharynx cancer	0.0041	0.00769	CbGeAlD
Sorafenib—MAP2K5—brainstem—pharynx cancer	0.00403	0.00756	CbGeAlD
Sorafenib—RALBP1—trachea—pharynx cancer	0.00395	0.00741	CbGeAlD
Sorafenib—MKNK2—lymphoid tissue—pharynx cancer	0.00381	0.00714	CbGeAlD
Sorafenib—KIT—parotid gland—pharynx cancer	0.00381	0.00714	CbGeAlD
Sorafenib—FGFR1—spinal cord—pharynx cancer	0.00376	0.00706	CbGeAlD
Sorafenib—MKNK1—lymphoid tissue—pharynx cancer	0.00376	0.00705	CbGeAlD
Sorafenib—FLT1—trachea—pharynx cancer	0.00375	0.00704	CbGeAlD
Sorafenib—RAF1—trachea—pharynx cancer	0.00373	0.007	CbGeAlD
Sorafenib—PDGFRB—parotid gland—pharynx cancer	0.00372	0.00698	CbGeAlD
Sorafenib—RET—lymphoid tissue—pharynx cancer	0.00371	0.00697	CbGeAlD
Sorafenib—EPHB6—trachea—pharynx cancer	0.00371	0.00696	CbGeAlD
Sorafenib—MAPK11—lymph node—pharynx cancer	0.00369	0.00693	CbGeAlD
Sorafenib—KIT—saliva-secreting gland—pharynx cancer	0.00365	0.00684	CbGeAlD
Sorafenib—CDK7—lymph node—pharynx cancer	0.00363	0.00682	CbGeAlD
Sorafenib—TAOK2—lymph node—pharynx cancer	0.0036	0.00676	CbGeAlD
Sorafenib—KDR—epithelium—pharynx cancer	0.00359	0.00673	CbGeAlD
Sorafenib—AURKC—lymph node—pharynx cancer	0.00358	0.00671	CbGeAlD
Sorafenib—KIT—brainstem—pharynx cancer	0.00357	0.0067	CbGeAlD
Sorafenib—MAP3K7—spinal cord—pharynx cancer	0.00356	0.00668	CbGeAlD
Sorafenib—PDGFRB—saliva-secreting gland—pharynx cancer	0.00356	0.00668	CbGeAlD
Sorafenib—PDGFRA—trachea—pharynx cancer	0.00352	0.0066	CbGeAlD
Sorafenib—MKNK2—spinal cord—pharynx cancer	0.00345	0.00648	CbGeAlD
Sorafenib—MKNK1—spinal cord—pharynx cancer	0.00341	0.00639	CbGeAlD
Sorafenib—FLT4—head—pharynx cancer	0.00339	0.00636	CbGeAlD
Sorafenib—RET—spinal cord—pharynx cancer	0.00337	0.00632	CbGeAlD
Sorafenib—FLT1—lymphoid tissue—pharynx cancer	0.00327	0.00614	CbGeAlD
Sorafenib—RAF1—lymphoid tissue—pharynx cancer	0.00325	0.0061	CbGeAlD
Sorafenib—KIT—epithelium—pharynx cancer	0.00318	0.00597	CbGeAlD
Sorafenib—KDR—trachea—pharynx cancer	0.00317	0.00595	CbGeAlD
Sorafenib—MAP2K5—trachea—pharynx cancer	0.00317	0.00595	CbGeAlD
Sorafenib—ZAK—lymph node—pharynx cancer	0.00314	0.00589	CbGeAlD
Sorafenib—RALBP1—spinal cord—pharynx cancer	0.00312	0.00585	CbGeAlD
Sorafenib—PDGFRB—epithelium—pharynx cancer	0.00311	0.00583	CbGeAlD
Sorafenib—CSF1R—trachea—pharynx cancer	0.0031	0.00581	CbGeAlD
Sorafenib—STK10—lymphoid tissue—pharynx cancer	0.00309	0.00581	CbGeAlD
Sorafenib—HIPK3—lymph node—pharynx cancer	0.00307	0.00577	CbGeAlD
Sorafenib—MKNK2—head—pharynx cancer	0.00307	0.00576	CbGeAlD
Sorafenib—PDGFRA—lymphoid tissue—pharynx cancer	0.00306	0.00575	CbGeAlD
Sorafenib—MKNK1—head—pharynx cancer	0.00303	0.00568	CbGeAlD
Sorafenib—RET—head—pharynx cancer	0.00299	0.00561	CbGeAlD
Sorafenib—FLT1—spinal cord—pharynx cancer	0.00296	0.00556	CbGeAlD
Sorafenib—RAF1—spinal cord—pharynx cancer	0.00295	0.00553	CbGeAlD
Sorafenib—HTR2C—brainstem—pharynx cancer	0.00294	0.00552	CbGeAlD
Sorafenib—EPHB6—spinal cord—pharynx cancer	0.00293	0.0055	CbGeAlD
Sorafenib—TIE1—lymph node—pharynx cancer	0.00287	0.00539	CbGeAlD
Sorafenib—KIT—trachea—pharynx cancer	0.00281	0.00528	CbGeAlD
Sorafenib—PDGFRA—spinal cord—pharynx cancer	0.00278	0.00521	CbGeAlD
Sorafenib—RALBP1—head—pharynx cancer	0.00277	0.0052	CbGeAlD
Sorafenib—KDR—lymphoid tissue—pharynx cancer	0.00276	0.00519	CbGeAlD
Sorafenib—BRAF—lymph node—pharynx cancer	0.00275	0.00517	CbGeAlD
Sorafenib—PDGFRB—trachea—pharynx cancer	0.00275	0.00515	CbGeAlD
Sorafenib—CSF1R—lymphoid tissue—pharynx cancer	0.0027	0.00506	CbGeAlD
Sorafenib—FLT1—head—pharynx cancer	0.00263	0.00494	CbGeAlD
Sorafenib—EPHX2—lymph node—pharynx cancer	0.00263	0.00494	CbGeAlD
Sorafenib—RAF1—head—pharynx cancer	0.00262	0.00492	CbGeAlD
Sorafenib—FLT3—lymph node—pharynx cancer	0.00261	0.0049	CbGeAlD
Sorafenib—EPHB6—head—pharynx cancer	0.0026	0.00489	CbGeAlD
Sorafenib—KDR—spinal cord—pharynx cancer	0.00251	0.0047	CbGeAlD
Sorafenib—MAP2K5—spinal cord—pharynx cancer	0.00251	0.0047	CbGeAlD
Sorafenib—STK10—head—pharynx cancer	0.00249	0.00468	CbGeAlD
Sorafenib—PDGFRA—head—pharynx cancer	0.00247	0.00463	CbGeAlD
Sorafenib—KIT—lymphoid tissue—pharynx cancer	0.00245	0.0046	CbGeAlD
Sorafenib—CSF1R—spinal cord—pharynx cancer	0.00245	0.00459	CbGeAlD
Sorafenib—PDGFRB—lymphoid tissue—pharynx cancer	0.00239	0.00449	CbGeAlD
Sorafenib—FLT4—lymph node—pharynx cancer	0.00237	0.00445	CbGeAlD
Sorafenib—FGFR1—lymph node—pharynx cancer	0.00234	0.00439	CbGeAlD
Sorafenib—KDR—head—pharynx cancer	0.00223	0.00418	CbGeAlD
Sorafenib—MAP2K5—head—pharynx cancer	0.00223	0.00418	CbGeAlD
Sorafenib—KIT—spinal cord—pharynx cancer	0.00222	0.00417	CbGeAlD
Sorafenib—MAP3K7—lymph node—pharynx cancer	0.00222	0.00416	CbGeAlD
Sorafenib—CSF1R—head—pharynx cancer	0.00217	0.00408	CbGeAlD
Sorafenib—PDGFRB—spinal cord—pharynx cancer	0.00217	0.00407	CbGeAlD
Sorafenib—MKNK2—lymph node—pharynx cancer	0.00215	0.00403	CbGeAlD
Sorafenib—MKNK1—lymph node—pharynx cancer	0.00212	0.00398	CbGeAlD
Sorafenib—RET—lymph node—pharynx cancer	0.00209	0.00393	CbGeAlD
Sorafenib—ABCG2—parotid gland—pharynx cancer	0.00209	0.00392	CbGeAlD
Sorafenib—ABCG2—saliva-secreting gland—pharynx cancer	0.002	0.00376	CbGeAlD
Sorafenib—KIT—head—pharynx cancer	0.00197	0.0037	CbGeAlD
Sorafenib—RALBP1—lymph node—pharynx cancer	0.00194	0.00364	CbGeAlD
Sorafenib—PDGFRB—head—pharynx cancer	0.00193	0.00362	CbGeAlD
Sorafenib—FLT1—lymph node—pharynx cancer	0.00184	0.00346	CbGeAlD
Sorafenib—RAF1—lymph node—pharynx cancer	0.00183	0.00344	CbGeAlD
Sorafenib—HTR2C—spinal cord—pharynx cancer	0.00183	0.00343	CbGeAlD
Sorafenib—EPHB6—lymph node—pharynx cancer	0.00182	0.00342	CbGeAlD
Sorafenib—STK10—lymph node—pharynx cancer	0.00175	0.00328	CbGeAlD
Sorafenib—PDGFRA—lymph node—pharynx cancer	0.00173	0.00324	CbGeAlD
Sorafenib—HTR2C—head—pharynx cancer	0.00163	0.00305	CbGeAlD
Sorafenib—MAP2K5—lymph node—pharynx cancer	0.00156	0.00293	CbGeAlD
Sorafenib—KDR—lymph node—pharynx cancer	0.00156	0.00293	CbGeAlD
Sorafenib—ABCC4—head—pharynx cancer	0.00153	0.00288	CbGeAlD
Sorafenib—HTR2B—head—pharynx cancer	0.00153	0.00287	CbGeAlD
Sorafenib—CSF1R—lymph node—pharynx cancer	0.00152	0.00286	CbGeAlD
Sorafenib—KIT—lymph node—pharynx cancer	0.00138	0.00259	CbGeAlD
Sorafenib—PDGFRB—lymph node—pharynx cancer	0.00135	0.00253	CbGeAlD
Sorafenib—CYP2D6—brainstem—pharynx cancer	0.00134	0.00252	CbGeAlD
Sorafenib—CYP2B6—lymphoid tissue—pharynx cancer	0.00124	0.00233	CbGeAlD
Sorafenib—ABCG2—spinal cord—pharynx cancer	0.00122	0.00229	CbGeAlD
Sorafenib—ABCC4—lymph node—pharynx cancer	0.00107	0.00202	CbGeAlD
Sorafenib—HTR2B—lymph node—pharynx cancer	0.00107	0.00201	CbGeAlD
Sorafenib—ABCC2—lymph node—pharynx cancer	0.00104	0.00195	CbGeAlD
Sorafenib—CYP2B6—head—pharynx cancer	0.000999	0.00188	CbGeAlD
Sorafenib—ABCB1—epithelium—pharynx cancer	0.000861	0.00162	CbGeAlD
Sorafenib—ABCB1—trachea—pharynx cancer	0.000761	0.00143	CbGeAlD
Sorafenib—ABCG2—lymph node—pharynx cancer	0.000759	0.00142	CbGeAlD
Sorafenib—CYP2D6—head—pharynx cancer	0.000743	0.00139	CbGeAlD
Sorafenib—ABCB1—lymphoid tissue—pharynx cancer	0.000663	0.00124	CbGeAlD
Sorafenib—ABCB1—spinal cord—pharynx cancer	0.000601	0.00113	CbGeAlD
Sorafenib—ABCB1—head—pharynx cancer	0.000534	0.001	CbGeAlD
Sorafenib—ABCB1—lymph node—pharynx cancer	0.000374	0.000702	CbGeAlD
Sorafenib—BRAF—MAPK Signaling Pathway—TP53—pharynx cancer	0.000361	0.000774	CbGpPWpGaD
Sorafenib—FGFR1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000357	0.000763	CbGpPWpGaD
Sorafenib—FGFR1—DAP12 interactions—EGFR—pharynx cancer	0.000357	0.000763	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000357	0.000763	CbGpPWpGaD
Sorafenib—PDGFRA—DAP12 interactions—EGFR—pharynx cancer	0.000356	0.000761	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000356	0.000761	CbGpPWpGaD
Sorafenib—PDGFRA—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000356	0.000761	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by EGFR—EGFR—pharynx cancer	0.000353	0.000756	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by EGFR—EGFR—pharynx cancer	0.000352	0.000755	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00035	0.00075	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000349	0.000748	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—EGFR—pharynx cancer	0.000349	0.000747	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by PDGF—EGFR—pharynx cancer	0.000349	0.000746	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by PDGF—EGFR—pharynx cancer	0.000348	0.000745	CbGpPWpGaD
Sorafenib—KIT—B Cell Activation—EGFR—pharynx cancer	0.000348	0.000744	CbGpPWpGaD
Sorafenib—MAP3K7—B Cell Activation—EGFR—pharynx cancer	0.000348	0.000744	CbGpPWpGaD
Sorafenib—PDGFRB—Downstream signal transduction—EGFR—pharynx cancer	0.000346	0.00074	CbGpPWpGaD
Sorafenib—RAF1—Focal Adhesion—CCND1—pharynx cancer	0.000344	0.000736	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by FGFR—EGFR—pharynx cancer	0.000344	0.000736	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—ADH7—pharynx cancer	0.000343	0.000735	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—ADH7—pharynx cancer	0.000343	0.000735	CbGpPWpGaD
Sorafenib—RAF1—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000343	0.000733	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000343	0.000733	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by ERBB2—EGFR—pharynx cancer	0.000342	0.000733	CbGpPWpGaD
Sorafenib—PDGFRB—DAP12 signaling—EGFR—pharynx cancer	0.000341	0.000729	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling by NGF—EGFR—pharynx cancer	0.000339	0.000725	CbGpPWpGaD
Sorafenib—MAPK11—Cellular Senescence—TP53—pharynx cancer	0.000336	0.00072	CbGpPWpGaD
Sorafenib—PDGFRA—Focal Adhesion—EGFR—pharynx cancer	0.000336	0.000719	CbGpPWpGaD
Sorafenib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000336	0.000719	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000336	0.000718	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000335	0.000716	CbGpPWpGaD
Sorafenib—RAF1—Disease—B4GALT5—pharynx cancer	0.000334	0.000716	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000334	0.000715	CbGpPWpGaD
Sorafenib—KIT—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000333	0.000712	CbGpPWpGaD
Sorafenib—CDK7—Cell Cycle, Mitotic—CCND1—pharynx cancer	0.000331	0.000708	CbGpPWpGaD
Sorafenib—FGFR1—B Cell Activation—EGFR—pharynx cancer	0.00033	0.000706	CbGpPWpGaD
Sorafenib—PDGFRA—B Cell Activation—EGFR—pharynx cancer	0.000329	0.000705	CbGpPWpGaD
Sorafenib—MAP3K7—MAPK Signaling Pathway—TP53—pharynx cancer	0.000329	0.000704	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—EGFR—pharynx cancer	0.000328	0.000702	CbGpPWpGaD
Sorafenib—RAF1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000328	0.000702	CbGpPWpGaD
Sorafenib—RAF1—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.000328	0.000702	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—CD79A—pharynx cancer	0.000327	0.0007	CbGpPWpGaD
Sorafenib—RAF1—Signaling by ERBB4—EGFR—pharynx cancer	0.000323	0.000691	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CNDP2—pharynx cancer	0.000322	0.00069	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00032	0.000686	CbGpPWpGaD
Sorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00032	0.000686	CbGpPWpGaD
Sorafenib—PDGFRB—DAP12 interactions—EGFR—pharynx cancer	0.00032	0.000686	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CNDP2—pharynx cancer	0.000319	0.000684	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by EGFR—EGFR—pharynx cancer	0.000318	0.00068	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000316	0.000676	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000316	0.000676	CbGpPWpGaD
Sorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000316	0.000676	CbGpPWpGaD
Sorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000315	0.000674	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000315	0.000674	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by PDGF—EGFR—pharynx cancer	0.000313	0.000671	CbGpPWpGaD
Sorafenib—FGFR1—MAPK Signaling Pathway—TP53—pharynx cancer	0.000312	0.000668	CbGpPWpGaD
Sorafenib—RAF1—Downstream signal transduction—EGFR—pharynx cancer	0.000308	0.000659	CbGpPWpGaD
Sorafenib—RAF1—Signaling by FGFR—EGFR—pharynx cancer	0.000307	0.000656	CbGpPWpGaD
Sorafenib—RAF1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000307	0.000656	CbGpPWpGaD
Sorafenib—RAF1—Signaling by ERBB2—EGFR—pharynx cancer	0.000305	0.000653	CbGpPWpGaD
Sorafenib—RAF1—DAP12 signaling—EGFR—pharynx cancer	0.000304	0.00065	CbGpPWpGaD
Sorafenib—RAF1—TGF-beta Signaling Pathway—TP53—pharynx cancer	0.000303	0.000649	CbGpPWpGaD
Sorafenib—PDGFRB—Focal Adhesion—EGFR—pharynx cancer	0.000303	0.000648	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—ADH1B—pharynx cancer	0.000301	0.000645	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—ADH1B—pharynx cancer	0.000301	0.000645	CbGpPWpGaD
Sorafenib—KDR—Axon guidance—EGFR—pharynx cancer	0.000299	0.000639	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000298	0.000637	CbGpPWpGaD
Sorafenib—PDGFRB—B Cell Activation—EGFR—pharynx cancer	0.000297	0.000635	CbGpPWpGaD
Sorafenib—CDK7—Cell Cycle—CCND1—pharynx cancer	0.000296	0.000633	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ADH7—pharynx cancer	0.000291	0.000624	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CD79A—pharynx cancer	0.000289	0.00062	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ADH7—pharynx cancer	0.000289	0.000618	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—B4GALT5—pharynx cancer	0.000288	0.000616	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—B4GALT5—pharynx cancer	0.000288	0.000616	CbGpPWpGaD
Sorafenib—RAF1—DAP12 interactions—EGFR—pharynx cancer	0.000286	0.000611	CbGpPWpGaD
Sorafenib—RAF1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000286	0.000611	CbGpPWpGaD
Sorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000286	0.000611	CbGpPWpGaD
Sorafenib—MAPK11—Signaling by NGF—EGFR—pharynx cancer	0.000284	0.000608	CbGpPWpGaD
Sorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000284	0.000607	CbGpPWpGaD
Sorafenib—RAF1—Signaling by EGFR—EGFR—pharynx cancer	0.000283	0.000606	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000282	0.000603	CbGpPWpGaD
Sorafenib—BRAF—Signaling by NGF—EGFR—pharynx cancer	0.000281	0.000602	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000281	0.000601	CbGpPWpGaD
Sorafenib—RAF1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000281	0.000601	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—TP53—pharynx cancer	0.00028	0.0006	CbGpPWpGaD
Sorafenib—RAF1—Signaling by PDGF—EGFR—pharynx cancer	0.000279	0.000598	CbGpPWpGaD
Sorafenib—RAF1—Focal Adhesion—EGFR—pharynx cancer	0.00027	0.000578	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000269	0.000575	CbGpPWpGaD
Sorafenib—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000262	0.00056	CbGpPWpGaD
Sorafenib—KIT—Immune System—CD79A—pharynx cancer	0.000261	0.000559	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CD79A—pharynx cancer	0.000261	0.000559	CbGpPWpGaD
Sorafenib—KIT—Signaling by NGF—EGFR—pharynx cancer	0.000256	0.000548	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ADH1B—pharynx cancer	0.000256	0.000547	CbGpPWpGaD
Sorafenib—MAPK11—Cellular responses to stress—TP53—pharynx cancer	0.000254	0.000544	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ADH1B—pharynx cancer	0.000253	0.000542	CbGpPWpGaD
Sorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000253	0.000541	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—TP53—pharynx cancer	0.00025	0.000535	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CD79A—pharynx cancer	0.000248	0.00053	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CD79A—pharynx cancer	0.000247	0.000529	CbGpPWpGaD
Sorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000244	0.000523	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.000244	0.000523	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by NGF—EGFR—pharynx cancer	0.000243	0.00052	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by NGF—EGFR—pharynx cancer	0.000242	0.000519	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—B4GALT5—pharynx cancer	0.000242	0.000518	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—CDH1—pharynx cancer	0.00024	0.000513	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—CDH1—pharynx cancer	0.00024	0.000513	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000236	0.000506	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000231	0.000494	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—CDH1—pharynx cancer	0.000227	0.000487	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—CDH1—pharynx cancer	0.000227	0.000486	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000226	0.000483	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD79A—pharynx cancer	0.000223	0.000476	CbGpPWpGaD
Sorafenib—FGFR1—Axon guidance—EGFR—pharynx cancer	0.00022	0.000471	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—EGFR—pharynx cancer	0.000218	0.000467	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ADH7—pharynx cancer	0.000214	0.000457	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—EGFR—pharynx cancer	0.000213	0.000456	CbGpPWpGaD
Sorafenib—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000211	0.000452	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000209	0.000447	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—CDH1—pharynx cancer	0.000204	0.000438	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.0002	0.000428	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD79A—pharynx cancer	0.000198	0.000425	CbGpPWpGaD
Sorafenib—CDK7—Cell Cycle—TP53—pharynx cancer	0.000195	0.000417	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—EGFR—pharynx cancer	0.000195	0.000416	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000187	0.000401	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—CCND1—pharynx cancer	0.000185	0.000396	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—EGFR—pharynx cancer	0.000183	0.000392	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000183	0.000392	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—CDH1—pharynx cancer	0.000182	0.00039	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—CCND1—pharynx cancer	0.000182	0.00039	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000181	0.000387	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.000179	0.000383	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000178	0.000382	CbGpPWpGaD
Sorafenib—RAF1—Axon guidance—EGFR—pharynx cancer	0.000176	0.000377	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000175	0.000375	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000174	0.000373	CbGpPWpGaD
Sorafenib—MKNK1—Disease—EGFR—pharynx cancer	0.000169	0.000362	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000164	0.000351	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000163	0.000348	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—EGFR—pharynx cancer	0.000162	0.000347	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000162	0.000346	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000161	0.000346	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CDH1—pharynx cancer	0.000161	0.000345	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000159	0.000339	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ADH7—pharynx cancer	0.000158	0.000337	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—EGFR—pharynx cancer	0.000157	0.000336	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000152	0.000324	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—CCND1—pharynx cancer	0.000151	0.000323	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000148	0.000318	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000147	0.000315	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—EGFR—pharynx cancer	0.000146	0.000312	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—EGFR—pharynx cancer	0.000146	0.000312	CbGpPWpGaD
Sorafenib—KIT—Immune System—CDH1—pharynx cancer	0.000145	0.000311	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CDH1—pharynx cancer	0.000145	0.000311	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—EGFR—pharynx cancer	0.000145	0.000311	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—EGFR—pharynx cancer	0.000143	0.000306	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000142	0.000303	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—EGFR—pharynx cancer	0.00014	0.0003	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—EGFR—pharynx cancer	0.00014	0.0003	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000139	0.000298	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—EGFR—pharynx cancer	0.000139	0.000297	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—EGFR—pharynx cancer	0.000138	0.000296	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000138	0.000296	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CDH1—pharynx cancer	0.000138	0.000295	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CDH1—pharynx cancer	0.000138	0.000295	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—CCND1—pharynx cancer	0.000136	0.000291	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000135	0.00029	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—EGFR—pharynx cancer	0.000133	0.000285	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—EGFR—pharynx cancer	0.000133	0.000284	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000132	0.000283	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.00013	0.000279	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000129	0.000276	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000127	0.000271	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000126	0.000269	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—EGFR—pharynx cancer	0.000126	0.000269	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—EGFR—pharynx cancer	0.000124	0.000266	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000124	0.000266	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CDH1—pharynx cancer	0.000124	0.000265	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000123	0.000264	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—TP53—pharynx cancer	0.000123	0.000263	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—TP53—pharynx cancer	0.000122	0.000261	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—TP53—pharynx cancer	0.00012	0.000257	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—EGFR—pharynx cancer	0.00012	0.000256	CbGpPWpGaD
Sorafenib—CDK7—Disease—EGFR—pharynx cancer	0.000119	0.000255	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—EGFR—pharynx cancer	0.000118	0.000253	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—EGFR—pharynx cancer	0.000111	0.000238	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CDH1—pharynx cancer	0.000111	0.000237	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.00011	0.000236	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000107	0.00023	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—EGFR—pharynx cancer	0.000107	0.000228	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—EGFR—pharynx cancer	0.000107	0.000228	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000106	0.000228	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000105	0.000226	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—TP53—pharynx cancer	0.000103	0.000222	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—TP53—pharynx cancer	9.94e-05	0.000213	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ADH7—pharynx cancer	9.71e-05	0.000208	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—EGFR—pharynx cancer	9.43e-05	0.000202	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—CCND1—pharynx cancer	9.27e-05	0.000199	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—CCND1—pharynx cancer	9.04e-05	0.000193	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—TP53—pharynx cancer	8.95e-05	0.000192	CbGpPWpGaD
Sorafenib—BRAF—Disease—EGFR—pharynx cancer	8.62e-05	0.000185	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ADH1B—pharynx cancer	8.51e-05	0.000182	CbGpPWpGaD
Sorafenib—KIT—Immune System—EGFR—pharynx cancer	8.5e-05	0.000182	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—EGFR—pharynx cancer	8.5e-05	0.000182	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	8.13e-05	0.000174	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—EGFR—pharynx cancer	8.07e-05	0.000173	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—EGFR—pharynx cancer	8.05e-05	0.000172	CbGpPWpGaD
Sorafenib—KIT—Disease—EGFR—pharynx cancer	7.85e-05	0.000168	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CCND1—pharynx cancer	7.77e-05	0.000166	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CCND1—pharynx cancer	7.7e-05	0.000165	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—EGFR—pharynx cancer	7.57e-05	0.000162	CbGpPWpGaD
Sorafenib—FGFR1—Disease—EGFR—pharynx cancer	7.45e-05	0.000159	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—EGFR—pharynx cancer	7.43e-05	0.000159	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—EGFR—pharynx cancer	7.28e-05	0.000156	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—EGFR—pharynx cancer	7.25e-05	0.000155	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—EGFR—pharynx cancer	7.09e-05	0.000152	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—EGFR—pharynx cancer	7.07e-05	0.000151	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CCND1—pharynx cancer	7.01e-05	0.00015	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CCND1—pharynx cancer	7.01e-05	0.00015	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—EGFR—pharynx cancer	6.69e-05	0.000143	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CCND1—pharynx cancer	6.65e-05	0.000142	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CCND1—pharynx cancer	6.63e-05	0.000142	CbGpPWpGaD
Sorafenib—RAF1—Immune System—EGFR—pharynx cancer	6.46e-05	0.000138	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TP53—pharynx cancer	6.11e-05	0.000131	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—EGFR—pharynx cancer	6.11e-05	0.000131	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—EGFR—pharynx cancer	6.1e-05	0.000131	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—EGFR—pharynx cancer	6.04e-05	0.000129	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CCND1—pharynx cancer	5.98e-05	0.000128	CbGpPWpGaD
Sorafenib—RAF1—Disease—EGFR—pharynx cancer	5.97e-05	0.000128	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TP53—pharynx cancer	5.95e-05	0.000127	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CCND1—pharynx cancer	5.7e-05	0.000122	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—EGFR—pharynx cancer	5.5e-05	0.000118	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—EGFR—pharynx cancer	5.5e-05	0.000118	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CCND1—pharynx cancer	5.33e-05	0.000114	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—EGFR—pharynx cancer	5.22e-05	0.000112	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—EGFR—pharynx cancer	5.2e-05	0.000111	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TP53—pharynx cancer	5.12e-05	0.00011	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TP53—pharynx cancer	5.07e-05	0.000109	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—EGFR—pharynx cancer	4.69e-05	0.0001	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TP53—pharynx cancer	4.62e-05	9.88e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TP53—pharynx cancer	4.62e-05	9.88e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CCND1—pharynx cancer	4.6e-05	9.84e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—EGFR—pharynx cancer	4.47e-05	9.57e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TP53—pharynx cancer	4.38e-05	9.38e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TP53—pharynx cancer	4.37e-05	9.35e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—EGFR—pharynx cancer	4.18e-05	8.94e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TP53—pharynx cancer	3.94e-05	8.43e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TP53—pharynx cancer	3.75e-05	8.04e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—EGFR—pharynx cancer	3.61e-05	7.72e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TP53—pharynx cancer	3.51e-05	7.51e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TP53—pharynx cancer	3.03e-05	6.48e-05	CbGpPWpGaD
